Bryan Jay Lawrence - 11 Jun 2024 Form 4 Insider Report for Cingulate Inc. (CING)

Role
Director
Signature
/s/ Shane J. Schaffer, Attorney-in-Fact
Issuer symbol
CING
Transactions as of
11 Jun 2024
Net transactions value
$0
Form type
4
Filing time
13 Jun 2024, 19:59:40 UTC
Previous filing
06 Mar 2024
Next filing
23 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CING Stock Option (right to Buy) Award $0 +5,000 $0.000000 5,000 11 Jun 2024 Common Stock 5,000 $1.18 Direct F1, F2
transaction CING Stock Option (right to Buy) Award +14,125 14,125 11 Jun 2024 Common Stock 14,125 $1.18 Direct F1, F3, F4
transaction CING Stock Option (right to Buy) Award $0 +10,000 $0.000000 10,000 12 Jun 2024 Common Stock 10,000 $0.7000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option grant was approved by Cingulate Inc.'s board of directors on March 4, 2024, subject to stockholder approval of Amendment No.1 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan (the "Amendment"). Cingulate's stockholders approved the Amendment on June 11, 2024.
F2 The option vests as follows: 50% on the six-month anniversary of the date of grant and the remaining shares on the twelve-month anniversary of the date of grant.
F3 The option vests on the one-year anniversary of the date of grant.
F4 The option was issued to the reporting person in lieu of cash retainer fees of $28,250.